Abstract
Diabetes mellitus (DM) comprises a group of common metabolic disorders sharing the phenotype of hyperglycemia. Several subtypes are described and today much is known about the causes. In complex interaction, genetics, environmental, social, and lifestyle factors contribute to a phenomenon that more and more often is being called a diabetic epidemic. Depending on the etiology of DM, factors involved may include reduced insulin secretion, decreased glucose usage of the body, and increased glucose production. DM causes a plethora of pathophysiological changes in multiple organ systems that impose a tremendous burden on individuals and health systems. In the US, DM is the leading cause of end-stage renal disease, lower extremity amputations, and adult blindness.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Note that paced respiration has rather historical reasons related to early studies and to make newer data comparable with them. For a more extended discussion see Chap. 4.
References
Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care. 2004;27:1458–86.
Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegeler D. Diabetic neuropathies – a statement by the American Diabetes Association. Diabetes Care. 2005;4:956–62.
Brunner EJ, Hemingway H, Walker BR, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation. 2002;106:2659–65.
Burger AJ, D’Elia JA, Weinrauch LA, Lerman I, Gaur A. Marked abnormalities in heart rate variability are associated with progressive deterioration of renal function in type I diabetic patients with overt nephropathy. Int J Cardiol. 2002;86:281–7.
Carnethon MR, Prineas RJ, Temprosa M, Zhang ZM, Uwaifo G, Molitch ME; Diabetes Prevention Program Research Group: The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care. 2006;29:914–919.
Charles M, Fleischer J, Witte DR, Ejskjaer N, Borch-Johnsen K, Lauritzen T, Sandbaek A. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study. Diabetologia. 2013;56:101–8.
Denver JW, Reed SF, Porges SW. Methodological issues in the quantification of respiratory sinus arrhythmia. Biol Psychol. 2007;74:286–94.
Diakakis GF, Parthenakis FJ, Mavrakis HE, et al. Association of impaired glucose tolerance with increased heart rate and subclinical inflammation. Hellenic J Cardiol. 2005;46:394–401.
Fakhrzadeh H, Yamini-Sharif A, Sharifi F, Tajalizadekhoob Y, Mirarefin M, Mohammadzadeh M, Sadeghian S, Badamchizadeh Z, Larijani B. Cardiac autonomic neuropathy measured by heart rate variability and markers of subclinical atherosclerosis in early type 2 diabetes. ISRN Endocrinol. 2012;2012:168264.
González-Clemente JM, Vilardell C, Broch M, Megia A, Caixà s A, Giménez-Palop O, Richart C, Simón I, MartÃnez-Riquelme A, Arroyo J, Mauricio D, Vendrell J. Lower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetes. Eur J Endocrinol. 2007;157:31–8.
Gottsäter A, Ahlgren AR, Taimour S, Sundkvist G. Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Clin Auton Res. 2006;16:228–34.
Haegele-Link S, Claus D, Dücker S, Vogt T, Birklein F. Evaluation of the autonomic nervous system using the FAN® device – range of normal and examples of abnormal. Open Neurol J. 2008;2:12–9.
Hsiao JY, Tien KJ, Hsiao CT, Weng HH, Chung TC, Hsieh MC. The relationship between diabetic autonomic neuropathy and diabetic risk factors in a Taiwanese population. J Int Med Res. 2011;39:1155–62.
Jaiswal M, Urbina EM, Wadwa RP, Talton JW, D’Agostino Jr RB, Hamman RF, Fingerlin TE, Daniels S, Marcovina SM, Dolan LM, Dabelea D. Reduced heart rate variability among youth with type 1 diabetes: the SEARCH CVD study. Diabetes Care. 2013a;36:157–62.
Jaiswal M, Urbina EM, Wadwa RP, Talton JW, D’Agostino Jr RB, Hamman RF, Fingerlin TE, Daniels SR, Marcovina SM, Dolan LM, Dabelea D. Reduced heart rate variability is associated with increased arterial stiffness in youth with type 1 diabetes: the SEARCH cardiovascular disease study. Diabetes Care. 2013b;36(8):2351–8.
Karayannis G, Giamouzis G, Cokkinos DV, Skoularigis J, Triposkiadis F. Diabetic cardiovascular autonomic neuropathy: clinical implications. Expert Rev Cardiovasc Ther. 2012;10:747–65.
Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 2010;59:1716–26.
Khandoker AH, Jelinek HF, Palaniswami M. Identifying diabetic patients with cardiac autonomic neuropathy by heart rate complexity analysis. Biomed Eng Online. 2009;8:3.
Koskinen T, Kähönen M, Jula A, Mattson N, Laitinen T, Keltikangas-Järvinen L, Viikari J, Välimäki I, Rönnemaa T, Raitakari OT. Metabolic syndrome and short heart rate variability in young adults. The cardiovascular risk in young Finns study. Diabet Med. 2009;26:354–61.
Krämer HK, Rolke R, Bickel A, Birklein F. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care. 2004;27:2386–91.
Lieb DC, Parson HK, Mamikunian G, Vinik AI. Cardiac autonomic imbalance in newly diagnosed and established diabetes is associated with markers of adipose tissue inflammation. Exp Diabetes Res. 2012;2012:878760.
May O, Arildsen H. Simple function tests for autonomic neuropathy have a higher predictive value on all-cause mortality in diabetes compared to 24-h heart rate variability. J Diabetes Complications. 2012;26:246–50.
Nishimura M, Hashimoto T, Kobayashi H, Fukuda T, Okino K, Yamamoto N, Nakamura N, Yoshikawa T, Takahashi H, Ono T. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemdialysis patients. Nephrol Dial Transplant. 2004;19:2532–8.
Orlov S, Bril V, Orszag A, Perkins BA. Heart rate variability and sensorimotor polyneuropathy in type 1 diabetes. Diabetes Care. 2012;35:809–16.
Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L. Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord. 2006;6:19. doi:10.1186/1471-2261-6-19.
Pitocco D, Santageli P, Fuso L, Zaccardi F, Longobardi A, Infusino F, Incalci RA, Lanza GA, Crea F, Ghirlanda G. Association between reduced pulmonary diffusion capacity and cardiac autonomic dysfunction in type 1 diabetes. Diabet Med. 2008;25:1366–9.
Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH, DCCT/EDIC Research Group. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 2009;119:2886–93.
Risk M, Bril V, Broadbridge C, Cohen A. Heart rate variability measurement in diabetic neuropathy: review of methods. Diabetes Technol Ther. 2001;3:63–76.
Schroeder EB, Chambless LE, Liao DP, Prineas RJ, Evans GW, Rosamond WD, Heiss G. Diabtes, glucose, insulin, and heart rate variability. Diabetes Care. 2005;28:668–74.
The Diabetes Control and Complications Trial Research Group. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes. 1988;37:476–81.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.
Thiyagarajan R, Subramanian SK, Sampath N, Madanmohan Trakroo, Pal P, Bobby Z, Paneerselvam S, Das AK. Association between cardiac autonomic function, oxidative stress and inflammatory response in impaired fasting glucose subjects: cross-sectional study. PLoS One. 2012;7(7):e41889.
Vinik AI. The conductor of the autonomic orchestra. Front Endocrinol (Lausanne). 2012;3:71.
Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26:1553–79.
Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH, EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in type 1 diabetes Mellitus. Diabetologia. 2005;48:164–71.
Wittling W, Wittling RA. Herzschlagvariabilität: Frühwarnsystem, Stress- und Fitnessindikator. Heiligenstadt: Eichsfeld-Verlag; 2012.
Ziegler D, Dannehl K, Muhlen H, Spuler M, Gries FA. Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med. 1992;9:806–14.
Ziegler D, Zentai C, Perz S, Rathmann W, Haastert B, Meisinger C, Lowel H, KORA Study Group. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes. 2006;114:153–9.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Ernst, G. (2014). Diabetes. In: Heart Rate Variability. Springer, London. https://doi.org/10.1007/978-1-4471-4309-3_15
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4309-3_15
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4308-6
Online ISBN: 978-1-4471-4309-3
eBook Packages: MedicineMedicine (R0)